Rebimastat-impurities | Pharmaffiliates

Rebimastat

Rebimastat had been in phase II/III clinical trials for the treatment of non small cell lung cancer. Reference standards of Rebimastat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Rebimastat - API Standards 
    [catalogue_number] => PA 18 91000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 499.67
    [form] => C23H41N5O5S
    [cas] => 259188-38-0
    [pslug] => 259188-38-0-rebimastat-api-pa1891000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 91000

Rebimastat - API Standards


  • Catalogue No.:PA 18 91000

  • CAS :

    259188-38-0

  • Molecular Formula : C23H41N5O5S

  • Molecular Weight : 499.67